You are here

Updates

WASHINGTON, D.C. — April 15, 2015 — The Sabin Vaccine Institute (Sabin) presented the 2015 Albert B. Sabin Gold Medal Award to Roger I. Glass, MD, PhD, director of the Fogarty International Center and associate director for international research at the National Institutes of Health. Dr. Glass was recognized for his many contributions to improving children’s health worldwide, including novel scientific research for the prevention of gastroenteritis from rotaviruses and noroviruses.

LONDON – April 7, 2015 – Sabin Foundation Europe, the UK partner of the Sabin Vaccine Institute (Sabin), today announced the appointment of Mr. John Cummins, Group Treasurer of the Royal Bank of Scotland, as chairman of Sabin Foundation Europe (SFE), and the election of Rt Hon Baroness Helene Hayman GBE, a member of the UK Parliament’s House of Lords, to the SFE Board of Trustees. Mr. Cummins has served on the SFE Board of Trustees since January 2013. Baroness Hayman has served on the Sabin Board of Trustees since July 2011 and will continue to do so as she joins the SFE Board.

WASHINGTON, D.C. — March 25, 2015 — The Sabin Vaccine Institute (Sabin) will present the Albert B. Sabin Humanitarian Award to Gary Michelson, MD, a distinguished orthopedic spinal surgeon and inventor, in recognition of his extraordinary philanthropy and commitment toward the control and elimination of neglected tropical diseases (NTDs) through high-level advocacy and vaccine research and development. He will be honored today at a private event with Sabin’s executive leadership, Board of Trustees and key members of the scientific community in Houston, Texas.

WASHINGTON, DC – March 6, 2015 – The members of the Dengue Vaccine Initiative (DVI) consortium, the International Vaccine Institute, the Johns Hopkins University International Vaccine Access Center, the Sabin Vaccine Institute and the World Health Organization, are delighted to announce the appointment of Professor Annelies Wilder-Smith as Senior Advisor to the DVI, effective immediately.

ISTANBUL, TURKEY—March 3, 2015—The International Association of Immunization Managers (IAIM) today assembled nearly 150 of its members from more than 70 countries to discuss how their diverse experiences can inform efforts to improve the performance of national immunization programs.

WASHINGTON, D.C. — January 14, 2015 — India was certified polio-free in 2014. Today, the country has its sights set on another public health victory: the elimination of lymphatic filariasis, a neglected tropical disease (NTD) that threatens nearly half of its population. To meet this ambitious goal, the Indian Ministry of Health & Family Welfare (MOHFW) has launched one of the largest public health campaigns in India’s history to provide more than 400 million people with free medication that could protect them from lymphatic filariasis.

WASHINGTON, D.C. — December 16, 2014 — The Sabin Vaccine Institute, through the Coalition against Typhoid (CaT) Secretariat, announced today that it has received an award of approximately US$ 5 million from the Bill & Melinda Gates Foundation to support the establishment of an Asia regional enteric fever surveillance network. The network will enable the systematic collection of data in order to fill knowledge gaps on the impact of severe typhoid and paratyphoid — diseases collectively referred to as enteric fever.

WASHINGTON, D.C. — December 10, 2014 — The Sabin Vaccine Institute (Sabin) today announced that its Board of Trustees unanimously appointed Axel Hoos, MD, PhD, to serve as the interim Chairman of the Board. Building upon the past successes of late Chairman Morton P. Hyman, Dr. Hoos will be instrumental to providing continuity to the institute and to Sabin’s efforts in launching new programs, clinical trials and advocacy campaigns around the world.

Washington, DC - December 4, 2014 Four eminent scientists have agreed to serve as U.S. Science Envoys beginning in January, 2015: Dr. Peter Hotez, Dr. Jane Lubchenco, Dr. Arun Majumdar, and Dr. Geri Richmond. Announced by President Obama in Cairo in June 2009, the U.S. Science Envoy program demonstrates the United States’ commitment to science, technology, and innovation as tools of diplomacy and economic growth.